• Return to Headlines

Shares of ACAD Up 0.6% Since Uptrend Call on Shares

By Nick Russo

SmarTrend identified an Uptrend for Acadia Pharmaceu (NASDAQ:ACAD) on September 9th, 2019 at $40.30. In approximately 1 month, Acadia Pharmaceu has returned 0.62% as of today's recent price of $40.55.

Over the past year, Acadia Pharmaceu has traded in a range of $14.01 to $44.85 and is now at $40.55, 189% above that low. The 200-day and 50-day moving averages have moved 1.88% higher and 3.70% higher over the past week, respectively.

ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company focuses on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company is currently working on the treatment of induced dysfunction in Parkinson's disease, schizophrenia, neuropathic pain, and glaucoma.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Acadia Pharmaceu shares.

Log in and add Acadia Pharmaceu (ACAD) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights acadia pharmaceu

Ticker(s): ACAD